367 related articles for article (PubMed ID: 28634996)
1. Molecular regulation and pharmacological targeting of the β-catenin destruction complex.
van Kappel EC; Maurice MM
Br J Pharmacol; 2017 Dec; 174(24):4575-4588. PubMed ID: 28634996
[TBL] [Abstract][Full Text] [Related]
2. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
3. WNT signalling: mechanisms and therapeutic opportunities.
Schulte G; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
6. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.
Kagey MH; He X
Br J Pharmacol; 2017 Dec; 174(24):4637-4650. PubMed ID: 28574171
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo.
Schaefer KN; Bonello TT; Zhang S; Williams CE; Roberts DM; McKay DJ; Peifer M
PLoS Genet; 2018 Apr; 14(4):e1007339. PubMed ID: 29641560
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.
Zimmerli D; Hausmann G; Cantù C; Basler K
Br J Pharmacol; 2017 Dec; 174(24):4600-4610. PubMed ID: 28521071
[TBL] [Abstract][Full Text] [Related]
9. Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.
DeBruine ZJ; Xu HE; Melcher K
Br J Pharmacol; 2017 Dec; 174(24):4564-4574. PubMed ID: 28941231
[TBL] [Abstract][Full Text] [Related]
10. The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma.
Bourroul GM; Fragoso HJ; Gomes JW; Bourroul VS; Oshima CT; Gomes TS; Saba GT; Palma RT; Waisberg J
Einstein (Sao Paulo); 2016; 14(2):135-42. PubMed ID: 27462886
[TBL] [Abstract][Full Text] [Related]
11. Determination of Rate-Limiting Factor for Formation of Beta-Catenin Destruction Complexes Using Absolute Protein Quantification.
Kitazawa M; Hatta T; Ogawa K; Fukuda E; Goshima N; Natsume T
J Proteome Res; 2017 Oct; 16(10):3576-3584. PubMed ID: 28810742
[TBL] [Abstract][Full Text] [Related]
12. The β-catenin destruction complex.
Stamos JL; Weis WI
Cold Spring Harb Perspect Biol; 2013 Jan; 5(1):a007898. PubMed ID: 23169527
[TBL] [Abstract][Full Text] [Related]
13. Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
Koyama-Nasu R; Hayashi T; Nasu-Nishimura Y; Akiyama T; Yamanaka R
Biochem Biophys Res Commun; 2015 Apr; 459(3):411-5. PubMed ID: 25735981
[TBL] [Abstract][Full Text] [Related]
14. Phase separation of Axin organizes the β-catenin destruction complex.
Nong J; Kang K; Shi Q; Zhu X; Tao Q; Chen YG
J Cell Biol; 2021 Apr; 220(4):. PubMed ID: 33651074
[TBL] [Abstract][Full Text] [Related]
15. APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes.
Parker TW; Neufeld KL
Sci Rep; 2020 Feb; 10(1):2957. PubMed ID: 32076059
[TBL] [Abstract][Full Text] [Related]
16. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
17. Dishevelled phase separation promotes Wnt signalosome assembly and destruction complex disassembly.
Kang K; Shi Q; Wang X; Chen YG
J Cell Biol; 2022 Dec; 221(12):. PubMed ID: 36342472
[TBL] [Abstract][Full Text] [Related]
18. Liquid-liquid phase separation drives the β-catenin destruction complex formation.
Shi Q; Kang K; Chen YG
Bioessays; 2021 Oct; 43(10):e2100138. PubMed ID: 34418117
[TBL] [Abstract][Full Text] [Related]
19. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
20. Feedback in the β-catenin destruction complex imparts bistability and cellular memory.
Cantoria MJ; Alizadeh E; Ravi J; Varghese RP; Bunnag N; Pond KW; Kettenbach AN; Ahmed Y; Paek AL; Tyson JJ; Doubrovinski K; Lee E; Thorne CA
Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2208787120. PubMed ID: 36598937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
